Skip to Content

IGF-1 LR3

Lyophilized Vial · Subcutaneous, Intramuscular Store refrigerated at 2-8 C and protect from heat and light. 99% Purity · USP Grade
99% Purity
PHYSICIAN USE ONLY
$ 69.00 $ 69.00

Format
💉 vial
  • Strength
Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days
Clinical Description

Muscle growth, fat reduction, recovery improvement, cellular repair, body recomposition, performance enhancement, anti-aging

IGF-1 LR3 es una versión modificada del factor de crecimiento similar a la insulina-1, diseñada para extender la vida media y aumentar la actividad anabólica. Promueve el crecimiento muscular, la reducción de grasa, una mejor recuperación y reparación celular al mejorar los efectos de la hormona del crecimiento natural. IGF-1 LR3 es muy buscado en protocolos de rendimiento, antienvejecimiento y recomposición corporal.

Clinical Indications
GH-axis optimization protocolsRecovery and lean-mass support plansSleep-linked anabolic pathway support
Recommended Stacking Protocols
✓
CJC-1295
Enhances GH and IGF-1 synergy
✓
Tesamorelin
Enhances GH and IGF-1 synergy
✓
AOD-9604
Complements lean mass gains and fat loss
✓
5-Amino-1MQ
For metabolic support

Mechanism of Action - Growth Hormone Peptides Pathway

Targeted Signaling
Supports protocol objectives for IGF-1 LR3.
Clinical Modulation
Allows dose and schedule adjustments by response.
Outcome Tracking
Pairs with clinician monitoring for iterative optimization.
Starting Dose
20-100mcg per day, post-workout
Initiation phase for tolerance and baseline response.
Titration
Escalate by protocol
Maintenance Range
Maintain physician-directed target
Adjust based on objective outcomes and physician review.
Suggested Dosing Notes

Dosis típica:20-100 mcg por día

Frecuencia:Una vez al día, post-entrenamiento

Ciclo:4-6 semanas seguidas de un descanso

Period Dose Phase Clinical Notes
Typical Dose 20-100mcg per day, post-workout maintenance 4-6 weeks followed by a break
Weeks 3-6 Escalation phase escalation Increase per protocol if tolerated.
Week 7+ Maintenance phase maintenance Maintain target dose and reassess monthly.
Preparation Protocol
  1. IGF-1 LR3 se suministra como polvo liofilizado.
  2. IGF-1 LR3 debe reconstituirse con agua bacteriostática antes de su uso.
  3. Elija el volumen de reconstitución según el tamaño del vial para facilitar la dosificación.
1
Inspect vial
Confirm vial integrity, lot, and expiration before use.
2
Aseptic reconstitution
Disinfect stopper and add bacteriostatic water slowly.
3
Gentle dissolution
Swirl gently until the solution is clear and homogeneous.
4
Prepare dose
Draw dose according to reconstitution conversion guidance.
Reconstitution & Dosing Guide
Standard 1 mL insulin syringe: 100 units = 1 mL

Total Peptide: 1 mg
BW: 1 mL
Concentration: 1,000mcg/mL (10mcg per unit)
Dose Units to Draw Volume (mL) Approx. Supply
25mcg 2.5 units - 50 doses
50mcg 5 units - 20 doses
100mcg 10 units - 10 doses
Identity
  • Product Name: IGF-1 LR3
  • Product Type: Vial | Subcutaneous or Intramuscular Injection
  • Strength Options: 1 mg
  • Available Strengths: 1mg
Quality & Purity
  • Purity: >= 99%
  • Sterility: Aseptic handling required
  • Purity: 99%+
Storage & Handling
  • Storage: 2-8 C refrigerated
  • Handling: Avoid heat, shaking, and direct light
  • Storage: Refrigerate after reconstitution (2-8°C)
  • Syringe Tip: Inject subcutaneously using a 0.5mL insulin syringe

Timing: Use consistent administration timing for stable protocol tracking.

Storage: Store refrigerated at 2-8 C and protect from heat and light.

Frequency: Frequency: Once daily,post-workout

Cycle: 4-6 weeks followed by a break

Injection Sites: Rotate approved injection sites to reduce local irritation risk.